EGFR and cancer: Although involvement of alternative pathways such as PLCγ or STATs activated by EGFR/HER1 in the effects of cSBL needs to be elucidated, our results suggest that applications of cSBL against the cancer cells that depend on the ErbB receptors for growth may provide great benefit as a type of chemotherapy.